Langzeitremission eines nephrotischen Syndroms
Authors:
- 24 January 2014
- journal article
- bild und-fall
- Published by Springer Nature in Der Nephrologe
- Vol. 9 (1) , 48-50
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rituximab Targets Podocytes in Recurrent Focal Segmental GlomerulosclerosisScience Translational Medicine, 2011
- A review of the current use of rituximab in autoimmune diseasesInternational Immunopharmacology, 2009
- Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosisTransplant International, 2007
- Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndromePediatric Nephrology, 2005
- Pathologic classification of focal segmental glomerulosclerosis: a working proposalAmerican Journal of Kidney Diseases, 2004